Ionis strikes deal to buy back lipid disease spinout Akcea

Ionis strikes deal to buy back lipid disease spinout Akcea

Source: 
Fierce Biotech
snippet: 

Ionis Pharmaceuticals has struck a deal to buy its lipid disorder spinout Akcea Therapeutics. The deal will see Ionis pay around $500 million to acquire the 24% of Akcea that it doesn’t already own.